Regulation of transgene expression is a major goal of gene therapy research. Previously, we have developed a complex adenovirus (Ad) vector with tetracycline-regulated expression of a Fas ligand (FasL)-green fluorescent protein (GFP) fusion protein. This vector delivered high levels of activity that was regulated by doxycycline. However, this regulation was limited by the low but significant background activity of the TRE promoter. Recently, the Tet-regulated transcriptional silencer, tTS, was reported to suppress efficiently basal TRE activity without affecting induced expression levels. Here, we report development of Ad vectors that incorporate tTS in combination with that of reverse transactivator (rtTA) coupled with TRE promoter driving transgene expression. Incorporation of tTS improved control of transgene expression in vitro, so that an induction range of over three orders of magnitude was achieved in some cell lines. Effective regulation of transgene expression was also seen in a mouse model in vivo, following systemic vector delivery. In the case of FasL-GFP expression, significant improvement in the control of apoptotic activity both in vitro and in a mouse hepatotoxicity model was demonstrated when using rtTA-tTS vectors. In conclusion, a highly effective transgene regulation system, deliverable by a single adenoviral vector, is now available. Gene Therapy (2005) 12, 504-511.
Introduction
Efficient regulation of transgene expression in target cells is one of the major goals in the field of gene transfer and therapy. Several approaches to regulated expression have been pursued. Some involve the use of promoters inducible by natural stimuli, such as hormones, 1 heavy metal ions, 2 or radiation. 3 However, these systems were inadequate due to the interference of the inducers with the endogenous gene expression. Experience with natural regulatable promoters led to the formulation of a set of requirements for an 'ideal' gene expression system suitable for gene therapy applications. These requirements include an inducible promoter with unique regulatory DNA sequences, an effector protein that efficiently recognizes and binds to those sequences (and to no other sites in the host genome), and the dose-dependent inducibiltiy of that effector protein by a small and cheap drug molecule that can be safely and repeatedly administered. In addition, none of these components should interact or interfere with any endogenous cellular processes, and should not elicit an immune response from the host. The tetracyclinecontrolled expression systems possess most of the aforementioned properties, and have been used successfully in many cell lines and in transgenic mice, delivering highly efficient regulation of gene expression, with extremely low background and an induction range of up to five orders of magnitude. 4 Both Tet-On and Tet-Off versions of the system are available, so called because the transgene expression is induced either in the presence (On) or in the absence (Off) of the regulating drug, tetracycline, or its derivatives. This flexibility was achieved by the development of the mutant form of Tet-responsive transcriptional transactivator (tTA), known as reverse, or rtTA. 5 Both versions of Tet regulation have also been incorporated into transient expression systems, including adenovirus (Ad) vectors. [6] [7] [8] Previously, we have described a complex Ad vector with the tTA expression cassette in the E1A region and the TRE promoter driving the expression of Fas ligand (FasL) and green fluorescent protein (GFP) fusion protein in a cloning site near the right ITR. 9 FasL is a type II transmembrane protein and is a member of the tumor necrosis factor family of cytokines. [10] [11] [12] It is a potent inducer of cell death through apoptosis in both normal and tumor cells, and the fusion FasL-GFP protein has similar activity. 13 Our vector delivered high levels of FasL-GFP activity that could be regulated by doxycycline, which is a widely accepted analog of tetracycline with a good safety profile in humans and an ability to regulate both tTA and rtTA with high specificity. [14] [15] [16] However, the extent of regulation achievable with our vector was limited to a range of between 20-and 70-fold (depending on the cell line), due to the low but significant background activity of the TRE promoter. 17 This activity, normally selected against in established cell lines and transgenic animals, has been reported in numerous transient expression studies. [18] [19] [20] Recently, an additional component has been developed to repress actively the TRE promoter in a Tetregulated manner. 21, 22 This transcriptional silencer, tTS, is a fusion between the Tet repressor and the KRAB domain from the human kidney protein Kid-1, 23 and it has been reported to suppress efficiently basal TRE activity without affecting induced expression levels in transient transfection studies. Here, we report construction and characterization of Ad vectors that incorporate tTS expression in combination with that of reverse transactivator (rtTA) in the E1A region, and TRE promoter driving either GFP or FasL-GFP expression near the right ITR. We show that vectors with tTS activity can be efficiently generated in 293 cells and do not adversely affect viability of cultured cell lines. Dox induces transgene expression in a concentration-dependent manner in cells transduced with vectors both with and without tTS activity, and maximum expression activity is comparable between the vectors expressing GFP. Moreover, the tTS-containing vector generated significantly lower background expression levels, which resulted in an expression range of over three orders of magnitude. The presence of tTS also allowed a significantly improved control of FasL-GFP expression, resulting in a more efficient regulation of FasL-induced apoptosis in several cell lines in vitro and in a CD-1 mouse liver following systemic vector delivery. In conclusion, a highly effective transgene regulation system incorporated into a single Ad vector for efficient delivery is now available.
Results
Inclusion of tTS into a Tet-regulated expression system delivered by a complex Ad vector greatly enhances the stringency of transgene expression
We have previously constructed and characterized complex Ad vectors that contain both expression cassettes of the Tet regulation system. 9, 24 Here, we have placed an additional expression cassette, that of Tetregulated transcriptional suppressor (tTS), into the left end of the Ad5 vector genome, directly following the rtTA expression cassette (Figure 1 ). In combination with transgene expression cassettes (GFP or FasL-GFP) inserted into the right end of the vector, we have created vectors capable of delivering the entire dual Tetregulated system on a single vector backbone. These vectors were generated and efficiently amplified to high titers in 293CrmA cells. Interestingly, we have noticed that rAd/FasL-GFP rTA/TS generated Infectious unit (IU) titers that were several fold higher than those produced by rAd/FasL-GFP rTA , with correspondingly better particle to IU ratios. 24 To evaluate the performance of the new vectors, we transduced a variety of different cell lines, derived from different human cell types, with both the rAd/GFP rTA and rAd/GFP rTA/TS vectors, both in the presence and absence of the inducer doxycyline. The results are summarized in Table 1 . Although both induced and uninduced levels of expression (as determined by GFP fluorescence) varied substantially between different cell lines, a consistently superior fold induction (that is, the ratio between induced and Figure 1 Adenoviral vectors used in this study. Vector genomes were assembled in vitro using the pL-Ad and pR-Ad shuttle vectors, as described in Materials and methods. The resulting vectors are E1 deleted and have a deletion in the E3 region (E3 promoter is retained). They also lack all of the E4 ORFs, except ORF6, which is expressed from the E4 promoter. Figure 1 . d,e,f Cells infected at an MOI of 10, 30 and 100, respectively.
Ad vectors deliver improved Tet regulation S Rubinchik et al uninduced expression) was seen in cells transduced with rAd/GFP rTA/TS . Thus, while fold induction in cells transduced with rAd/GFP rTA varied from 6 to 73, the range for the rAd/GFP rTA/TS fold induction extended from 46 to a very impressive 1894. This improvement in regulation was observed in every cell line tested, and was achieved not by increasing the induced expression activity (which was found to be essentially the same for the two vectors), but almost entirely by the reduction of the uninduced, or background, activity (Table 1 ). This point is further emphasized in the qualitative (visual) evaluation of the nontransformed human foreskin fibroblast (HFF) cells transduced with the two vectors (Figure 2 ), where the induced activity of both vectors appears to be very similar (panels c and d), while the background fluorescence generated by the rAd/ GFP rTA/TS vector (panel b) is clearly less than that produced by rAd/GFP rTA (panel a).
Next, we wished to determine the ability of these vectors not just to induce but to regulate transgene expression in response to different levels of doxycyline in culture medium. Doxycyline dose-repsonse curves to both rAd/GFP rTA and rAd/GFP rTA/TS vectors were generated in two different cell lines, LNCaP and MCF-7 ( Figure 3 ). Cell lines were infected using IU to cell ratios previously determined to transduce between 90 and 100% of the cells and to generate comparable levels of GFP fluorescence per well. Very similar expression profiles were obtained in both cell lines ( Figure 3 ). Both vectors demonstrated a full range of expression (note the log scale) in response to increasing concentrations of dox, but transduction with rAd/GFP rTA/TS resulted in a broader range of transgene regulation, particularly at the lower concentrations of dox (0 and 10 ng/ml), when compared to transduction with rAd/GFP rTA ( Figure 3 ). Therefore, incorporation of tTS into a complex Ad vectordelivered Tet expression system did not alter either the levels of induced expression or the overall profile of doxdependent regulation, but it did result in improved performance specifically by reducing the levels of uninduced background expression.
rAd/GFP rTA/TS vector delivers superior and dox dosedependent regulation of GFP expression in vivo
Once we established that inclusion of the tTS expression cassette resulted in greatly improved transgene regulation in vitro, we proceeded to evaluate the performance of our vectors in vivo, using a murine systemic vector dispersion model and a simple quantitative GFP fluorescence assay. To validate this assay, we injected CD-1 mice through the tail vein with rAd/GFP TA vector, and harvested several internal organs 24 h later. We took advantage of GFP's high stability in an aqueous environment and, following several cycles of tissue disruption (repeatedly grinding organs frozen in liquid nitrogen), extracted each organ homogenate with PBS containing 1% Triton X-100 detergent. As can be seen in Figure 4a , we obtained a GFP expression pattern comparable to those previously reported for other Ad5-delivered reporter genes. 25 Specifically, expression in the liver was at least 10-fold higher than in any other organ. Also, despite the fact that liver had close to 90% of overall expression, GFP expression was detected in all other organs. After liver, spleen had the highest level of expression, followed by the heart, lungs and kidneys ( Figure 4a ). Expression appeared to be inducible in all organs, although fold induction varied from 35 in spleen to 3 in kidney. Next, we injected CD-1 mice with either rAd/GFP rTA/TS or rAd/GFP rTA vector, and at the same time injected them with different doses of doxycycline. We concentrated our evaluation on GFP expression in the liver, where dox dose-dependent GFP fluorescence was observed for both vectors ( Figure 4b ). As in vitro, rAd/ GFP rTA/TS performance was superior, with lower background and an overall induction of 108-fold, in comparison to less than 5-fold induction for rAd/GFP rTA . Interestingly, rAd/GFP TA generated somewhat higher maximal expression in the liver than either of the rtTA vectors, and had fold induction of 18 -significantly better than rAd/GFP rTA . Previously, we have shown that Ad vectors delivering a proapoptotic FasL-GFP gene under the control of the TetOff system expressed high levels of that protein under induced conditions and could efficiently kill a variety of cancer cells. 9, 13 However, a number of cell lines were found to be very sensitive to FasL-GFP activity, and significant levels of apoptosis were observed in transduced cells in the absence of induction. We were therefore interested in evaluating the ability of the new tTS-incorporating FasL-GFP vector to control levels of apoptosis in both sensitive and resistant cells.
Two cell lines previously characterized as sensitive (A549 and HeLa) as well as two cell lines that are somewhat FasL-resistant (MCF-7 and B-CAP) were infected with rAd/FasL-GFP rTA/TS , rAd/FasL-GFP rTA or rAd/GFP TA at increasing IU to cell ratios in either the presence or absence of dox. In all cell lines, induction of either FasL-GFP vector resulted in a virtually identical pattern of decreasing cell viability in response to increasing MOI ( Figure 5 ). In the absence of dox, somewhat reduced levels of cell death were observed in MCF-7 and B-CAP cells transduced with rAd/FasL-GFP rTA vector, but in the sensitive HeLa and A549 cells almost no difference due to the state of induction could be observed ( Figure 5 ). In contrast, uninduced rAd/ FasL-GFP rTA/TS had only a small negative effect on cell viability, even at an MOI as high as 135, and in fact its activity was comparable to that of the negative control vector, rAd/GFP TA ( Figure 5 ).
To characterize vector-mediated FasL-GFP regulation in vivo, male CD-1 mice were infected systemically, through tail vein injection, with 1 Â 10 9 IU of rAd/FasL-GFP rTA or rAd/FasL-GFP rTA/TS , or mock infected with an equal volume of 1 Â HEPES-buffered saline buffer (HBS). FasL-GFP expression was induced in vectorinfected groups by administering dox at 4 mg/g body weight. Since liver is the primary organ targeted by Ad5 vectors and where highest levels of transgene expression are seen following systemic infection (see Figure 4a) , we examined livers of our mice 24 h after infection. Induction of both FasL-GFP vectors with dox led to significant liver damage, high levels of in situ TUNEL staining and rapid (within 24 h) death of the animals. Figure 6d shows hematoxylin and eosin (H&E) and TUNEL analysis of one such mouse, infected with rAd/FasL-GFP rTA/TS . Virtually identical results were seen in mice infected with rAd/FasL-GFP rTA under induced conditions (not shown). In the absence of induction, all vector-infected mice survived and did not exhibit any significant Ad vectors deliver improved Tet regulation S Rubinchik et al changes in behavior. However, examination of livers of mice infected with rAd/FasL-GFP rTA revealed some tissue damage, and fairly significant levels of apoptosis in some regions of the liver (Figure 6b) . The rAd/FasL-GFP rTA/TS vector, on the other hand, demonstrated little hepatotoxicity as its tissue histology and TUNEL staining patterns resembled those of the mock-infected mouse's liver sections (Figure 6c and a, respectively).
Discussion
Despite significant progress that has been made recently in eliminating adenoviral genes from Ad vector design, first-generation Ad vectors remain widely used and important tools, both in basic research and in the clinic. This is due to the relative ease with which these vectors can be constructed and purified to very high titers, as well as a wide body of knowledge about their properties and performance gained from numerous animal studies and clinical trials. First-generation Ad vectors are especially useful in cancer gene therapy, since the highlevel but transient transgene expression they induce is favorable for applications where the goal is the destruction of the target cells, and therefore, prolonged expression is not necessary and could be potentially harmful if a toxic protein were persistently expressed. In a large number of cases, both research and clinical application of Ad vectors require the ability to regulate tightly transgene expression, and numerous expression regulation systems have been incorporated into these vectors. 26, 27 We, as well as other researchers, chose to employ the tetracycline-controllable expression system, 9 which has several advantages over other regulated gene expression systems. It uses components of the tetracycline operon derived from bacteria, which ensures tight and interference-free regulation. In addition, well-characterized and safe inducers of the system (tetracycline and doxycycline) are available. 4, 5, 16 Two types of Tetregulatable systems, Tet-Off and Tet-On, have been developed, and both have been successfully used to regulate transgene expression in established cell lines and transgenic animals. 4 Previously, we described a strategy to combine both the transactivator and the transgene expression cassettes on a single vector backbone, as this arrangement has advantages in both uniform delivery of regulatable expression and in the reduced production costs. 9 However, we (as well as others) soon determined that in the context of the adenoviral vector, the Tet system was 'leaky', that is, there were significant amounts of expression in the uninduced state, primarily due to the background activity of the TRE promoter, and also to some enhancer interference coming from Ad regulatory elements. 17, 20 In the context of anticancer vectors delivering highly cytotoxic genes such as FasL-GFP fusion protein, such background expression could be damaging to normal cells and tissues.
In an attempt to improve the performance of the Tet system in our vectors, we incorporated an additional element -the tTS, generated as a fusion between TetR and KRAB domain of Kid-1. 22 The ability of this protein to suppress the background expression of the Tet-On system without diminishing induced activity levels has previously been reported for several transient expression systems, including adenoviral vectors. 22, 23, 28 The tTS expression cassette was inserted into an Ad vector in combination with the rtTA expression cassette, as well as the TRE-driven transgene expression cassette. 24 Thus, all of the components of the combined Tet activation/ repression system were incorporated into a single Ad vector for maximum efficiency of delivery, expression and vector production ( Figure 1) . We chose to use individual CMV promoters to drive the expression of both rtTA and tTS, so that high levels of both regulatory proteins would be generated in target cells. During Figure 6 Incorporation of TS into an rAd vector delivering rTA-regulated FasL-GFP Ad results in better regulation of hepatotoxicity. CD-1 mice were injected into the tail vein with 100 ml of either (a) HBS; (b) 10 10 IU/ml rAd.FasL-GFP rTA ; (c) 10 10 IU/ml rAd.FasL-GFP rTA/TS ; or (d) 10 10 IU/ml rAd.FasL-GFP rTA/TS plus 4 mg/g body weight doxycycline. Liver sections were prepared as described in Materials and methods. Top panels -TUNEL; bottom panels -H&E staining.
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vector scale-up and purification, the effects of tTS activity could already be observed, as the 293CrmA cultures of tTS-containing vectors had significantly reduced levels of GFP fluorescence. In the case of vectors expressing FasL-GFP, presence of tTS resulted in several fold higher IU titers and better IU to total particle ratios following vector purification. 24 In itself, this aspect of tTS activity is a significant benefit for production of Ad vectors that deliver Tet-regulated expression of cytotoxic genes.
Using our rAd/GFP rTA and rAd/GFP rTA/TS vectors and a large number of cell lines originating from different tissues, we have determined that tTS activity efficiently reduces transgene expression levels in the absence of induction, but does not alter the induced expression levels or the overall profile of the dox doseresponse curve (Table 1, Figures 2 and 3) . This observation is in good agreement with the known mechanism of tTS activity as well as with the previous reports on its performance. 22, 23 Interestingly, when using a newer generation of rtTA proteins 15 in Ad vectors, Mizuguchi et al 28 observed significantly higher expression levels in the presence of tTS expression than in its absence. So far, that is the only study reporting this tTS effect on the activity of the Tet-On system, and no mechanism for it has as yet been proposed. Although the activity of our Tet-On system (with or without tTS) varied in a cell linedependent manner, the inclusion of tTS resulted in a significant improvement in fold induction in all cell lines (Table 1) . Currently, the reasons for variable Tet system performance in different cell types are not fully determined, but, in addition to cell type-based variability in efficiency of Ad5 vector transduction, a large factor appears to be the stability of rtTA mRNA and its effect on the levels of the rtTA protein expressed in the cell. 15, 29, 30 In our study, transduction with the rAd/GFP rTA/TS resulted in induction that varied from 46-fold in A549 to almost 1900-fold in SF295. This performance compares very favorably with previously described transient Tet systems (both plasmid and viral based), which typically achieve between seven-and 350-fold induction. 27 We were interested in evaluating the ability of our vectors to regulate transgene expression in an in vivo model. Specifically, the original rtTA system was reported to work rather poorly in vivo, as compared to the tTA-based Tet-Off system. 31 We were also rather surprised to learn that while numerous induction/ repression studies have been carried out, successful in vivo regulation of transgene expression by varying the dose of the inducer drug (doxycycline in this case) has not been previously described for viral vector Tet system. We decided to compare both of our rtTA-based vectors with the original Tet-Off GFP-expressing vector, rAd/ GFP TA , in a murine systemic infection study. We used a very simple but novel technique to detect and quantify GFP expression in various mouse organs. We were able to show that dose-dependent transgene expression could be established in vivo using the Ad vector-delivered Tet system, and that tTS activity significantly improved the performance of the Tet-On system using the original rtTA. In terms of maximum expression levels, Tet-Off system was somewhat superior to both rtTA and rtTA+tTS systems (Figure 4 ), in agreement with previously published studies, but rAd/GFP rTA/TS delivered the best fold induction in our hands. A further improvement in the system should result when the rtTA is replaced by one of the new generation rtTAs, rtTA-M2 or rtTA-S2. 15, 28, 31 As we have observed previously, background expression from our FasL-GFP expressing vectors (both Tet-Off and Tet-On regulated) could result in significant reduction of cell viability, a problem that had to be overcome before the use of this type of vector in the clinical setting could be safely considered. In vitro, we were able to determine that rAd/FasL-GFP rTA/TS vector had substantially reduced cytotoxicity in the absence of induction, in comparison to rAd/FasL-GFP rTA . This effect was observed in both FasL-sensitive and FasL-resistant cells, even at high IU to cell ratios ( Figure 5 ). Encouraged, we addressed an often mentioned concern regarding the use of cytotoxic adenoviral vectors for cancer gene therapyspecifically, that an accidental release into systemic circulation will cause vector localization to the liver and significant hepatotoxicity due to some FasL-GFP expression. Following systemic administration of these vectors into CD-1 mice, we found that, as expected, induction of FasL-GFP expression was associated with disruption of liver tissues and major levels of apoptosis ( Figure 6 ), rapidly leading to animal's death. In the absence of induction all injected mice survived, but examination of the livers has revealed that rAd/FasL-GFP rTA treatment did cause some apoptosis and tissue damage in certain liver section, while rAd/FasL-GFP rTA/TS exhibited no detectable hepatotoxicity ( Figure 6 ) Thus, a vast improvement in being able to control and regulate cytotoxic transgene expression has been achieved with this new adenoviral vector.
In summary, we have developed a complex adenoviral vector with greatly reduced background transgene expression achieved without compromising induced expression levels. This design can generate over 1000-fold induction of gene expression and promotes increased production of active viral particles during vector propagation. The reduced hepatotoxicity and tight gene regulation conferred by this adenoviral vector makes it a good candidate for use in preclinical and clinical studies of gene transfer, particularly in the cancer gene therapy strategy using the FasL-GFP fusion protein. . All cell lines were maintained in DMEM (Mediatech Inc., Herndon, VA, USA) supplemented with 10% cosmic calf serum (HyClone, Logan, UT, USA) and 1% penicillin/ streptomycin, in humidified incubators at 371C and 5% CO 2 .
Materials and methods
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Adenoviral vectors
Construction of pR-Ad.T.GFP, 17 pL-Ad.C.tTA and pRAd.T.FasL-GFP 9 shuttle vectors has been described previously, as was the construction of pL-Ad-C.rtTA and rAd/FasL-GFP rTA vectors. 24 The XhoI-ClaI fragment of pUHS 6-1 (generously contributed by H Bujard, Center for Molecular Biology, University of Heidelberg, Heidelberg, Germany), containing the CMV promoter and the tTS gene, was inserted into a unique XhoI site at the end of the BGH polyA site within the pL-Ad.C.rtTA shuttle plasmid vector to generate pL-Ad.C.rtTA-C.tTS. Adenoviral vectors were assembled using the following combinations of pL-Ad and pR-Ad shuttle vectors: pLAd-C.rtTA and pR-Ad-T.GFP to construct rAd/GFP rTA ; pL-Ad-C.tTA and pR-Ad-T.GFP to construct rAd/GFP TA ; pL-Ad-C.rtTA-C.tTS and pR-Ad-T.GFP to construct rAd/ GFP rTA/TS ; and pL-Ad-C.rtTA-C.tTS and pR-Ad.T.FasL-GFP to construct rAd/FasL-GFP rTA/TS . The genomes of recombinant Ad vectors were assembled in vitro and transfected into 293CrmA cells as described previously. 24 The cultures were propagated until virus-induced cytopathic effects were observed. Primary vector stocks were amplified according to established techniques, banded twice using CsCl 2 gradient ultracentrifugation and desalted twice using PD-10 columns (Amersham Pharmacia Biotech, San Francisco, CA, USA) against 1 Â HBS (Molecular Cloning: A Laboratory Manual) according to the manufacturer's instructions. Vector structures are as sketched in Figure 1 .
Calculation of IU
Total viral particles per ml were determined by absorbance at 260 nm in the presence of 0.1% SDS. IU per ml were obtained by serial dilution on 293CrmA cells in 96-well plates, with titers scored based on GFP fluorescence, as described previously. 24 
GFP fluorescence detection and quantification in vitro
Cells were seeded on 24-well plates (Greiner, Frickenhausen, Germany) at 5 Â 10 4 cells/well and allowed to attach for 5 h. The wells were then infected with an appropriate rAd vector at the desired MOI for each particular experiment. Doxycycline was added to appropriate wells to the required final concentrations. Efficiency of infection was monitored 24 h postinfection by visualizing GFP fluorescence in cells using Axiovert-25 fluorescent microscope (Zeiss Optical Systems Inc., Thornwood, NY, USA) and FITC excitation/emission filter set (Chroma Technology Corp., Brattleboro, VT, USA). When required, photographs ( Â 100 magnification) were taken using an attached Pixera Professional digital camera (Pixera Corp., Los Gatos, CA, USA). To determine relative expression levels of either GFP or FasL-GFP proteins, cells from each well were removed to a 1.5 ml Eppendorf tube 48 h postinfection, washed once with 1 Â PBS and resuspended in 150 ml of 1Â PBS containing 1% Triton X-100. Cells were lysed by a brief incubation at room temperature followed by gentle vortexing and a brief centrifugation. Sample supernatants were then transferred to wells of a 96-well black plate (BMG Labtechnologies, Durham, NC, USA). Relative GFP fluorescence was determined using FLUOstart dual fluorescence/absorbance plate reader (BMG Labtechnologies) with 485 nm excitation and 520 nm emission filter set.
Determination of in vivo GFP expression
Male CD-1 mice were purchased from Charles River Laboratory (Charleston, SC, USA). These mice were 8 weeks old with average weight of 25.672.3 g. In all, 10 groups of three mice per group were infected by tail vein injection with 1 Â 10 9 IU of the desired viral vector in 200 ml of 1 Â HBS. As a control, 200 ml of 1 Â HBS was injected into the tail vein of one group of mice. Where indicated, doxycycline (1 mg/ml in H 2 O) was injected intraperitoneally (i.p.) at 0.1, 0.8 or 4 mg/g body weight (as indicated) immediately following vector injection (t ¼ 0 h). Mice were killed by cervical dislocation at t ¼ 24 h, and their livers, lungs, kidneys, hearts and spleens were removed and frozen at À801C. Subsequently, these organs were ground into a powder in a mortar in the presence of liquid nitrogen, transferred to 1.5 ml preweighed tubes and weighed. Two volumes of 1 Â PBS containing 1% Triton X-100 (v/w) were added to each tube and the mixtures were vigorously vortexed and placed at 371C. Following a 30 min incubation, mixtures were vortexed again and centrifuged at 21 000 g for 20 min. A measure of 200 ml of each supernatant was transferred to wells of a black 96-well plate, and relative GFP fluorescence was determined as described above. In all cases, fluorescence of control (HBS-injected) tissues was used as background and was subtracted from fluorescence measurements.
In vitro cell viability assay
To determine cytotoxic activity of rAd vectors expressing FasL-GFP protein, cells were seeded and infected as described above. At 48 h postinfection, culture media from wells were removed and replaced with 200 ml of serum-free RPMI 1640 and 40 ml CellTiter 96 s AQueous One Solution Assay reagent (Promega, Madison, WI, USA). Plates were incubated at 371C for 1 h, and 200 ml of supernatant from each well was transferred to a flatbottomed 96-well ELISA plate. Absorbance at 492 nm (related to number of viable cells) was determined using FLUOstart dual fluorescence/absorbance plate reader. Ratio of absorbance in wells transduced with Ad vectors to that of uninfected cells was used to determine percent viable cells remaining in vector-treated wells.
Systemic toxicity assay and histological staining
Five groups of three CD-1 mice were injected through the tail vein with 1 Â 10 9 IU of the desired viral vector as described above. Where indicated, doxycycline (1 mg/ ml in H 2 O) was injected i.p. at 4 mg/g body weight immediately following vector injection (t ¼ 0 h) and again the next day (t ¼ 24 h). Mice were killed by cervical dislocation at t ¼ 48 h, and their livers were removed. The livers were covered with Tissue-Tek O.C.T. Compound (Sakura Finetek Inc., Torrance, CA, USA) and snap-frozen on dry ice. Frozen sections (6 mm thick) were prepared using a Cryostat microtome, adhered to glass slides and stained with H&E according to established procedures. Alternatively, to measure apoptosis induction, we labeled nuclear sections with FITC using the In Situ Death Detection kit, POD (Roche Diagnostics Corp., Indianapolis, IN, USA), according to the manufacturer's Ad vectors deliver improved Tet regulation S Rubinchik et al instructions. Photographs of the slides at Â 100 magnification were taken with a high-resolution digital camera.
